MAP Online Tools

A suite of best-in-class Market Access tools that save you time in planning, used regularly by our consultants these tools are practical and comprehensive. Available to MAP Online members as part of the membership fee, or at a highly subsidised rate. Tools can also be purchased for a one-off fee by non-MAP Online members.

Revenue Forecast Model

What is the Revenue Forecast Model tool?

 A proven tool to support your prediction of manufacturing requirements and sales by country over time, including a breakdown of total patient population based on fields to capture your epidemiology assumptions through to patient discontinuations

Who is it for?

 Market Access, Pricing and Commercial professionals

When would this tool be used?

 Two to three years pre-commercialisation, companies plan for development of commercial teams (often including Market Access at this ‘late’ stage)

 They need to understand the likely revenue that may be achieved in a range of scenarios. Company models tend to be comprehensive, which can lead to missing important points in the detail

How does the tool help?

 Countries, regions, foreign exchange rates, epidemiology, eligibility and continuation/discontinuation all combine to provide a company with revenues by country and globally

 Cross referencing the main corporate model with this market access focussed model can help to challenge assumptions and avoid ‘group think’

Tool price

 MAP Online member fee: £5,000, non-member fee: £12,000

MAP Online
MAP Online Tools
MAP Online Tools

Revenue Forecast Model

What is it?

A proven tool to support your prediction of manufacturing requirements and sales by country over time, including a breakdown of total patient population based on fields to capture your epidemiology assumptions through to patient discontinuations

Who is it for?

Market Access, Pricing and Commercial professionals

When would it be used?

Two to three years pre-commercialisation, companies plan for development of commercial teams (often including Market Access at this ‘late’ stage)

They need to understand the likely revenue that may be achieved in a range of scenarios. Company models tend to be comprehensive, which can lead to missing important points in the detail

How does it help?

Countries, regions, foreign exchange rates, epidemiology, eligibility and continuation/discontinuation all combine to provide a company with revenues by country and globally

Cross referencing the main corporate model with this market access focussed model can help to challenge assumptions and avoid ‘group think’

Price

MAP Online member fee: £5,000, non-member fee: £12,000

CareersTerms and ConditionsComplaints ProcedurePrivacy PolicyCookie Policy

Copyright © 2021.
MAP BioPharma Limited.
All rights reserved.

MAP BioPharma Limited
Upper Pendrill Court, Ermine Street North
Papworth Everard, Cambridge
Cambridgeshire, CB23 3UY
United Kingdom

 +44 (0) 1480 832360

 enquiries@mapbiopharma.com

MAP BioPharma Limited is a registered company in England and Wales.
Company Registration Number 08209281

VAT Group Registration Number:
GB 292 8576 52